Zobrazeno 1 - 10
of 262
pro vyhledávání: '"Kanji, Takahashi"'
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Hiroshi Onishi, Junko Morii, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 10, Pp 2629-2644 (2024)
Abstract Introduction This study evaluated the cost-effectiveness of anti-vascular endothelial growth factor (VEGF) therapies for subtypes of neovascular age-related macular degeneration (nAMD) from the societal perspective, and for any nAMD from the
Externí odkaz:
https://doaj.org/article/d2dd1258d1754fc3827dbb4d69d7b1a6
The effect of fibroblast growth factor 2 on neovascular vessels depends on the stage of angiogenesis
Autor:
Yuki Hattori, Haruhiko Yamada, Hidetsugu Mori, Shinpei Oba, Kaito Yokota, Masatoshi Omi, Yuichi Yamamoto, Keiko Toyama, Masayuki Ohnaka, Kanji Takahashi, Hisanori Imai
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39843- (2024)
Objective: The exact relationship between fibroblast growth factor 2 (FGF2) and choroidal neovascularization (CNV) remains unclear. In this study, using optical coherence tomography angiography (OCTA) and FGF2-tg mice which are transgenic mice with a
Externí odkaz:
https://doaj.org/article/443db9cccb914a34ae4d12c11e60041c
Autor:
Fumi Gomi, MD, PhD, Tomohiro Iida, MD, PhD, Ryusaburo Mori, MD, PhD, Shinya Horita, PhD, MBA, Hiroaki Nakamura, MS, Yu Nakajima, MMath, Ayako Shiokawa, BPharm, Kanji Takahashi, MD, PhD
Publikováno v:
Ophthalmology Science, Vol 4, Iss 6, Pp 100553- (2024)
Purpose: To evaluate the safety, pharmacokinetics, and exploratory efficacy of tivozanib eye drops in healthy volunteers and patients with neovascular age-related macular degeneration (nAMD). Design: This multicenter group-sequential dose escalation
Externí odkaz:
https://doaj.org/article/253a962412cb45579d474c28151d8585
Autor:
Yukiko Sato, MD, Naoko Ueda-Arakawa, MD, PhD, Ayako Takahashi, MD, PhD, Masahiro Miyake, MD, PhD, Yuki Mori, MD, PhD, Yasunori Miyara, MD, Chikako Hara, MD, PhD, Yoko Kitajima, MD, Ruka Maruko, MD, PhD, Moeko Kawai, MD, Hajime Takahashi, MD, PhD, Hideki Koizumi, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Yasuo Yanagi, MD, PhD, Tomohiro Iida, MD, PhD, Kanji Takahashi, MD, PhD, Taiji Sakamoto, MD, PhD, Akitaka Tsujikawa, MD, PhD
Publikováno v:
Ophthalmology Science, Vol 4, Iss 5, Pp 100528- (2024)
Purpose: To elucidate the clinical characteristics and progression rates of pachychoroid and conventional geographic atrophy (GA). Design: Retrospective, multicenter, observational study. Participants: A total of 173 eyes from 173 patients (38 eyes w
Externí odkaz:
https://doaj.org/article/2e51602773874982b668c9ae7b319791
Publikováno v:
BMC Ophthalmology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Intravitreal anti-vascular endothelial growth factor (VEGF) is a mainstream treatment for reducing ME secondary to BRVO (BVO-ME). Regrettably, most reports of intravitreal anti-VEGF for BVO-ME have disclosed only short-term outcom
Externí odkaz:
https://doaj.org/article/09d9a21637744fc09533b3b408a01889
Autor:
Masatoshi Omi, Haruhiko Yamada, Hajime Takahashi, Hidetsugu Mori, Shimpei Oba, Yuki Hattori, Kaito Yokota, Keiko Toyama, Kanji Takahashi
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27160- (2024)
Objective: Retinal vein occlusion (RVO) can lead to visual impairment, but the development of collateral vessels can sometimes mitigate significant damage. This study aimed to investigate the relationship between collateral vessels and hypertension,
Externí odkaz:
https://doaj.org/article/ed91a1acbbd143a5832cfad5ed269f97
Autor:
Ramin Tadayoni, Glenn J. Jaffe, Frank G. Holz, Ursula Schmidt-Erfurth, Kanji Takahashi, Chui Ming Gemmy Cheung, Seenu M. Hariprasad, Kinfemichael Gedif, Rasmus Olsen, Catherine Best, Franklin Igwe, Peter K. Kaiser
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 4, Pp 2209-2216 (2023)
Abstract Introduction The HAWK and HARRIER studies evaluated the efficacy and safety of brolucizumab versus aflibercept in treatment-naïve eyes with neovascular age-related macular degeneration. Based on the study design, brolucizumab-treated eyes a
Externí odkaz:
https://doaj.org/article/7fdc7736c96b45888e4698c7d337b076
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii, Eriko Kunikane, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 4, Pp 2005-2021 (2023)
Abstract Introduction Neovascular age-related macular degeneration (nAMD) is the world’s leading cause of blindness in elderly people. While anti-vascular endothelial growth factor (VEGF) treatments are used as the first option for patients with nA
Externí odkaz:
https://doaj.org/article/1c8ea6a198a141b39076c05cade60bd9
Autor:
Kanji Takahashi, Tatsuro Nishikino, Hiroki Kajino, Seiji Kojima, Takayuki Uchihashi, Michio Homma
Publikováno v:
Biophysics and Physicobiology, Vol 20 (2023)
The marine bacterium Vibrio alginolyticus has a single flagellum as a locomotory organ at the cell pole, which is rotated by the Na+-motive force to swim in a liquid. The base of the flagella has a motor composed of a stator and rotor, which serves a
Externí odkaz:
https://doaj.org/article/c413b519ce5b4819a0e7845305359e01
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii, Eriko Kunikane, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 5, Pp 2821-2822 (2023)
Externí odkaz:
https://doaj.org/article/69898440c1b84610abdd8d9fb5086f10